Free-breathing, Contrast Agent-free Whole-Heart MTC-BOOST Imaging: Single-Center Validation Study in Adult Congenital Heart Disease.

Cardiac MR Angiography

Journal

Radiology. Cardiothoracic imaging
ISSN: 2638-6135
Titre abrégé: Radiol Cardiothorac Imaging
Pays: United States
ID NLM: 101748663

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 07 07 2022
revised: 07 12 2022
accepted: 13 12 2022
entrez: 2 3 2023
pubmed: 3 3 2023
medline: 3 3 2023
Statut: epublish

Résumé

To assess the clinical performance of the three-dimensional, free-breathing, Magnetization Transfer Contrast Bright-and-black blOOd phase-SensiTive (MTC-BOOST) sequence in adult congenital heart disease (ACHD). In this prospective study, participants with ACHD undergoing cardiac MRI between July 2020 and March 2021 were scanned with the clinical T2-prepared balanced steady-state free precession sequence and proposed MTC-BOOST sequence. Four cardiologists scored their diagnostic confidence on a four-point Likert scale for sequential segmental analysis on images acquired with each sequence. Scan times and diagnostic confidence were compared using the Mann-Whitney test. Coaxial vascular dimensions at three anatomic landmarks were measured, and agreement between the research sequence and the corresponding clinical sequence was assessed with Bland-Altman analysis. The study included 120 participants (mean age, 33 years ± 13 [SD]; 65 men). The mean acquisition time of the MTC-BOOST sequence was significantly lower compared with that of the conventional clinical sequence (9 minutes ± 2 vs 14 minutes ± 5; The MTC-BOOST sequence provided efficient, high-quality, and contrast agent-free three-dimensional whole-heart imaging in ACHD, with shorter, more predictable acquisition time and improved diagnostic confidence compared with the reference standard clinical sequence.

Identifiants

pubmed: 36860831
doi: 10.1148/ryct.220146
pmc: PMC9969217
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e220146

Subventions

Organisme : British Heart Foundation
ID : PG/18/59/33955
Pays : United Kingdom

Informations de copyright

© 2023 by the Radiological Society of North America, Inc.

Déclaration de conflit d'intérêts

Disclosures of conflicts of interest: A. Fotaki No relevant relationships. K.P. No relevant relationships. R.H. No relevant relationships. A.S. No relevant relationships. H.A. No relevant relationships. J.F. No relevant relationships. R.N. Employment contract with Siemens Healthcare; patent related to the technique used in the study (patent no. 20190064299); shareholder in Siemens Healthineers. K.P.K. Employee of Siemens Healthcare. A. Frigiola Provided study material, supervision, data analysis, and proofreading for this study; participation in regular governance meetings. R.M.B. Patent related to the technique used in the study (patent no. 20190064299). C.P. Patent related to the technique used in the study (patent no. 20190064299).

Références

Br Heart J. 1976 Apr;38(4):327-40
pubmed: 1267978
Magn Reson Med. 2003 Nov;50(5):892-903
pubmed: 14586999
J Cardiovasc Magn Reson. 2018 Nov 26;20(1):76
pubmed: 30474554
J Cardiovasc Magn Reson. 2022 Jan 10;24(1):5
pubmed: 35000609
Circulation. 2010 Apr 6;121(13):e266-369
pubmed: 20233780
J Magn Reson Imaging. 2010 Nov;32(5):1255-61
pubmed: 21031533
J Magn Reson Imaging. 2022 Jan;55(1):61-80
pubmed: 33078512
J Cardiovasc Magn Reson. 2013 Jun 13;15:51
pubmed: 23763839
J Cardiovasc Magn Reson. 2015 Apr 18;17:29
pubmed: 25928314
Radiology. 2021 Jul;300(1):162-173
pubmed: 33876971
Magn Reson Imaging. 2022 Oct;92:120-132
pubmed: 35772584
Radiographics. 2012 May-Jun;32(3):E107-27
pubmed: 22582368
Magn Reson Med. 2018 Mar;79(3):1460-1472
pubmed: 28722267
Circulation. 2015 Aug 25;132(8):755-61
pubmed: 26304667
J Magn Reson Imaging. 2023 Feb;57(2):521-531
pubmed: 35642573
Magn Reson Med. 1995 May;33(5):689-96
pubmed: 7596274
J Cardiovasc Magn Reson. 2021 Jul 12;23(1):94
pubmed: 34247640
Magn Reson Imaging. 2020 Jul;70:155-167
pubmed: 32353528
Magn Reson Med. 2021 Nov;86(5):2837-2852
pubmed: 34240753
Front Pediatr. 2017 Feb 27;5:36
pubmed: 28289674
Circulation. 2004 Jul 13;110(2):163-9
pubmed: 15210590
Magn Reson Med. 2017 May;77(5):1894-1908
pubmed: 27221073
Magn Reson Med. 2019 Feb;81(2):1066-1079
pubmed: 30230609
Magn Reson Med. 2002 Feb;47(2):372-83
pubmed: 11810682
Magn Reson Med. 2021 Mar;85(3):1195-1208
pubmed: 32924188
Magn Reson Med. 2013 Feb;69(2):486-94
pubmed: 22529009

Auteurs

Anastasia Fotaki (A)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Kuberan Pushparajah (K)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Reza Hajhosseiny (R)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Alina Schneider (A)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Harith Alam (H)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Joana Ferreira (J)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Radhouene Neji (R)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Karl P Kunze (KP)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Alessandra Frigiola (A)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

René M Botnar (RM)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Claudia Prieto (C)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, Westminster Bridge Road, Lambeth Wing, 3rd Floor, London SE1 7EH, England (A. Fotaki, K.P., R.H., A.S., J.F., R.N., K.P.K., A. Frigiola, R.M.B., C.P.); Department of MRI in Congenital Heart Disease, Guy's and St Thomas' NHS Foundation Trust, London, England (K.P., H.A., A. Frigiola); MR Research Collaborations, Siemens Healthcare Limited, Frimley, England (R.N., K.P.K.); and School of Engineering and Millennium Institute for Intelligent Healthcare Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile (R.M.B., C.P.).

Classifications MeSH